Laura Fernández Landó

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Insulin Resistance

Top Venues

Diabetes, obesity & metabolism

Diabetes therapy : research, treatment and education of diabetes and related disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Bertrand Cariou, Jennifer Linge, Ian J Neeland, Olof Dahlqvist Leinhard, Mikael Petersson, Laura Fernández Landó, Ross Bray, Angel Rodríguez
Effect of tirzepatide on body fat distribution pattern in people with type 2 diabetes. Diabetes, obesity & metabolism (2024)
Kristina Secnik Boye, Jiat Ling Poon, Laura Fernández Landó, Hélène Sapin, Ruth Huh, Mianbo Wang, Suzanne Williamson, Hiren Patel
Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6). Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Kristina Secnik Boye, Jiat Ling Poon, Laura Fernández Landó, Hélène Sapin, Ruth Huh, Mianbo Wang, Suzanne Williamson, Hiren Patel
Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6). Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Bertrand Cariou, Jennifer Linge, Ian J Neeland, Olof Dahlqvist Leinhard, Mikael Petersson, Laura Fernández Landó, Ross Bray, Angel Rodríguez
Effect of tirzepatide on body fat distribution pattern in people with type 2 diabetes. Diabetes, obesity & metabolism 26 (6) (2024)
Kristina Secnik Boye, Jiat Ling Poon, Laura Fernández Landó, Hélène Sapin, Ruth Huh, Mianbo Wang, Suzanne Williamson, Hiren Patel
Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6). Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Kristina Secnik Boye, Jiat Ling Poon, Laura Fernández Landó, Hélène Sapin, Ruth Huh, Mianbo Wang, Suzanne Williamson, Hiren Patel
Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6). Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Kristina Secnik Boye, Jiat Ling Poon, Laura Fernández Landó, Hélène Sapin, Ruth Huh, Mianbo Wang, Suzanne Williamson, Hiren Patel
Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6). Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Bertrand Cariou, Jennifer Linge, Ian J Neeland, Olof Dahlqvist Leinhard, Mikael Petersson, Laura Fernández Landó, Ross Bray, Angel Rodríguez
Effect of tirzepatide on body fat distribution pattern in people with type 2 diabetes. Diabetes, obesity & metabolism 26 (6) (2024)
Julio Rosenstock, Clare J Lee, Laura Fernández Landó, Minzhi Liu, Chrisanthi A Karanikas, Vivian T Thieu
Impact on glycated haemoglobin and body weight changes after stopping tirzepatide for 4 weeks in the SURPASS-1 monotherapy trial. Diabetes, obesity & metabolism (2023)
Sue D Pedersen, Francesco Giorgino, Guillermo E Umpierrez, Vivian T Thieu, Angel Rodríguez, Claudia Nicolay, Laura Fernández Landó, Chrisanthi A Karanikas, Jacek Kiljanski
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme. Diabetes, obesity & metabolism (2023)
Adie Viljoen, Kevin M Pantalone, Rodolfo J Galindo, Xuewei Cui, Ruth Huh, Andrea Hemmingway, Laura Fernández Landó, Hiren Patel
Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Guillermo E Umpierrez, Kevin M Pantalone, Charles M Atisso, Laura Fernández Landó, Hiren Patel
Relative contribution of basal and postprandial hyperglycaemia stratified by HbA1c categories before and after treatment intensification with dulaglutide. Diabetes, obesity & metabolism 21 (6) (2019)
Kevin M Pantalone, Hiren Patel, Maria Yu, Laura Fernández Landó
Dulaglutide 1.5 mg as an add-on option for patients uncontrolled on insulin: Subgroup analysis by age, duration of diabetes and baseline glycated haemoglobin concentration. Diabetes, obesity & metabolism 20 (6) (2018)